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Human pluripotent stem cell-based 
models suggest preadipocyte 
senescence as a possible cause of 
metabolic complications of Werner 
and Bloom Syndromes
Kim Jee Goh1, Jian-Hua chen1,2, nuno Rocha1,2 & Robert K. Semple3,1,2 ✉
Werner Syndrome (WS) and Bloom Syndrome (BS) are disorders of DnA damage repair caused by 
biallelic disruption of the WRn or BLM DnA helicases respectively. Both are commonly associated 
with insulin resistant diabetes, usually accompanied by dyslipidemia and fatty liver, as seen in 
lipodystrophies. in keeping with this, progressive reduction of subcutaneous adipose tissue is 
commonly observed. to interrogate the underlying cause of adipose tissue dysfunction in these 
syndromes, CRISPR/Cas9 genome editing was used to generate human pluripotent stem cell (hPSC) 
lacking either functional WRN or BLM helicase. No deleterious effects were observed in WRN−/− or 
BLM−/− embryonic stem cells, however upon their differentiation into adipocyte precursors (AP), 
premature senescence emerged, impairing later stages of adipogenesis. the resulting adipocytes 
were also found to be senescent, with increased levels of senescent markers and senescence-
associated secretory phenotype (SASp) components. SASp components initiate and reinforce 
senescence in adjacent cells, which is likely to create a positive feedback loop of cellular senescence 
within the adipocyte precursor compartment, as demonstrated in normal ageing. Such a scenario 
could progressively attenuate adipose mass and function, giving rise to “lipodystrophy-like” insulin 
resistance. further assessment of pharmacological senolytic strategies are warranted to mitigate this 
component of Werner and Bloom syndromes.
An estimated 425 million people were living with diabetes in 2017, a number projected to increase to 629 million 
by 20451. 90% of this is accounted for by type 2 diabetes (T2D), intimately related to increasing obesity. Obesity 
is also associated with a wider constellation of metabolic abnormalities, including insulin resistance (diminished 
responsiveness of an organism to the hypoglycaemic action of insulin2), and metabolic dyslipidaemia, which 
individually or collectively drive end organ diseases such as polycystic ovarian disease, fatty liver disease and 
atherosclerosis. Propensity to develop obesity-related metabolic disease shows significant heritability3–6, but the 
mechanistic basis of this has proved hard to tease out, in part because causation cannot be inferred from associ-
ations alone.
Severe “obesity-related” metabolic complications are also seen in a heterogeneous group of disorders known 
as lipodystrophies, in which adipose development or function is impaired. The paradox of obesity-related com-
plications in the face of absent or reduced adipose tissue has been rationalised by invoking “adipose failure” as a 
unifying feature of lipodystrophy and obesity. According to this notion, metabolic disease ensues when adipose 
tissue fails to discharge its physiological function as an “energy buffer” which sequesters and stores energy in the 
face of positive energy balance. Without this buffer other insulin-responsive organs are subjected to lipotoxic 
stress and ectopic lipid storage. In the case of generalised lipodystrophy adipose failure is absolute, while in obe-
sity it is relative, with the storage capacity of the tissue overwhelmed by excessive demand.
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Besides frank monogenic lipodystrophy, in which severe metabolic disease is associated with obvious defi-
ciency of adipose tissue, there are a range of more complex, pleiotropic disorders which feature dyslipidaemic 
insulin resistance and diabetes with lesser anatomical abnormality of adipose distribution, sometimes only grad-
ually becoming apparent with age. Several of these are caused by defects in genes involved in the cellular response 
to DNA damage. The canonical examples are Werner Syndrome (WS) and Bloom Syndrome (BS), rare autoso-
mal recessive disorders caused by loss-of-functions mutations in WRN and BLM respectively7–9. WRN and BLM 
are ubiquitously expressed RECQ helicases involved in a wide variety of repair processes required to maintain 
genomic integrity10. Patients with WS display clinical features of premature aging, including childhood onset 
insulin resistant diabetes mellitus, dyslipidaemia, and fatty liver with manifest atherosclerosis from the third 
decade7,8,11,12 as well as early greying, cataracts and cancers. BS patients typically exhibit post-natal growth retar-
dation, a facial ‘butterfly’ rash on sun exposure, defective cellular and humoral immunity, and increased cancer 
risk, but also are reported to exhibit a high prevalence of diabetes mellitus, dyslipidaemia and fatty liver13,14. Both 
syndromes thus metabolically phenocopy lipodystrophy and obesity, and some reduction of subcutaneous adi-
pose tissue is reported in both syndromes7,14. We thus hypothesised that premature adipose failure is at the root 
of the metabolic disease in these, and perhaps other, DNA damage repair disorders.
Accumulation of cellular DNA damage triggers cellular senescence. Mesenchymal stem cells, one of the 
major sources of adipose stem or progenitor cells, have been reported to exhibit premature senescence in WS 
patients15,16, while fibroblasts lacking functional WRN or BLM also show increased tendency to undergo senes-
cence17,18. Dysfunctional adipose tissue from obese and/or aged subjects also harbours an increased density of 
senescent cells19, while adipose progenitor cells show diminished ability to differentiate into functional adipo-
cytes19–21. Senescent cells exhibit a senescence-associated secretory phenotype, denoting elaboration of proin-
flammatory cytokines and chemokines such as Interleukin-6 (IL-6), IL-8 and Monocyte Chemoattractant 
Protein-1 (MCP-1). These have a negative impact on adipose tissue and insulin sensitivity by inducing paracrine 
senescence in adjacent cells22–29. Both genetic and pharmacological studies have established proof of the concept 
that clearing of senescent cells in adipose tissue can ameliorate systemic metabolism. Increasing understanding 
of the role played by senescence in adipose tissue in metabolic complications of WS and BS may thus afford new 
opportunity for precision therapy with senolytic agents in these disorders. Using WRN-/- and BLM-/- human pluri-
potent stem cell lines generated using CRISPR/Cas9, this study aimed to model the adipose tissue phenotype seen 
in WS and BS patients to assess the role played by senescence at different stages of adipose development.
Results
Generation of WRN- and BLM-deficient human embryonic stem cell (ESC) lines. To generate a 
WS cellular model using the well characterised H9 pluripotent human stem cell line, an sgRNA targeting exon 3 
of the WRN gene was used (Fig. 1a). 24 colonies were picked for screening after targeting, and all but 2 wild-type 
clones were found to have biallelic gene disruption. No heterozygous clones were observed. Targeting efficiency 
determined by the percentage of mutated alleles was thus 92%. One wild-type (WRN+/+) and one mutant clone 
(WRN−/−) were selected for further study. The WRN−/− clone selected harboured a homozygous 1 bp insertion 
(c.163insT), creating a premature stop codon (p.Y56Vfs*2) (Fig. 1a,b). The frameshift mutation disrupted WRN 
protein expression as determined by immunoblotting (Fig. 1c).
The BS cellular model was generated using an sgRNA targeting exon 3 of the BLM gene (Fig. 2a). Targeting 
efficiency was 52.1% with only one clone (BLM−/−) showing biallelic gene disruption, which was due to a homozy-
gous 11 bp deletion (c.381_392del; p.V127Pfs*11) (Fig. 2a,b). Nine clones out of 24 were found to be wild-type. 
Multiple attempts at immunoblotting failed to detect BLM protein in wild-type or targeted cells, so a functional 
assay was used instead to validate successful BLM disruption. A hallmark of BS is an increased rates of sister 
chromatid exchange (SCE), giving a “harlequin-like” chromosomal appearance on karyotyping after labelling 
of replicating DNA with BrdU30,31, which is the basis of diagnostic cytogenetic testing. The chromosomes of the 
BLM−/− clone had a classical harlequin-like appearance consistent with functional deficiency of BLM (Fig. 2c,d).
characterization of WRN−/− and BLM−/− heScs. All ESC colonies exhibited typical human ESC 
morphology, with no differences in colony morphology apparent either between WRN+/+ and WRN−/− ESCs 
or between BLM+/+ and BLM−/− ESCs (Supplementary Figure S1a). All lines stained positively for pluripotent 
markers OCT4 and NANOG (Supplementary Figure S1b). WRN+/+, WRN−/−, BLM+/+ and BLM−/− ESCs could 
be differentiated into all 3 germ layers, staining positively for SOX17, BRACHYURY and NESTIN, markers for 
endoderm, mesoderm and neurectoderm respectively (Supplementary Figure S1c). Loss of WRN or BLM thus 
does not compromise ESC pluripotency in culture.
Loss of WRN or BLM also did not affect proliferation rates of ESCs (Fig. 3a). As both WRN and BLM play 
important roles in telomere maintenance, telomere lengths were determined using a qPCR-based technique32. No 
significant differences in telomere lengths were found between WRN−/− and BLM−/− ESCs and their wild-type 
counterparts (Fig. 3b). Expression of telomerase components telomerase RNA component (TERC) and telomer-
ase reverse transcriptase (TERT) showed no significant differences between WRN+/+ and WRN−/− ESCs, while 
dyskerin (DKC1) was slightly increased at the mRNA level (Fig. 3c). mRNA expression of TERC and DKC1 
did not differ between BLM+/+ and BLM−/− ESCs, but expression of TERT was mildly increased. Taking find-
ings together, we conclude that the loss of WRN or BLM in ESCs does not impair proliferation nor significantly 
perturb telomere maintenance in ESCs.
WRN−/− and BLM−/− adipocyte precursor (Ap) cells show increased senescence. To assess cel-
lular phenotypes potentially relevant to putative adipose dysfunction in WS and BS, WRN+/+, WRN−/−, BLM+/+ 
and BLM−/− ESCs were first differentiated into CD73+ AP cells33 (Supplementary Figure S2a). Differentiation 
efficiency was equally high across all lines (>90%) (Supplementary Figure S2b). AP cells derived from all 4 ESC 
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lines were adherent to plastic and had fibroblastic morphology (Supplementary Figure S2c), indicating that loss 
of WRN or BLM does not interfere with the ability of ESCs to differentiate into AP cells.
Proliferation of WRN+/+, WRN−/−, BLM+/+ and BLM−/− AP cells was monitored over 10 days and WRN−/− 
and BLM−/− AP cells were both found to proliferate at a slower rate than wild-type counterparts (Fig. 4a). 
WRN−/− and BLM−/− AP cells were also found to have shorter telomeres (Fig. 4b). In line with prior studies, 
TERT expression was no longer detectable in AP cells (Data not shown). Expression of DKC1 was not affected by 
knockout of BLM or WRN, while a slight increase in TERC expression in both cases is presumed to be insignifi-
cant for telomere maintenance given absence of TERT (Fig. 4c).
AP cells were next stained for SA-β-gal, a commonly used senescence biomarker. WRN−/− and BLM−/− AP 
cells contained a significantly higher proportion of SA-β-gal-positive cells (Fig. 5a,b). Expression of senescence 
markers p16, p21, Interleukin-6 (IL-6) and IL-8 were assessed by qPCR and all were also upregulated in WRN−/− 
and BLM−/− AP cells (Fig. 5c), consistent with activation of senescence gene expression programmes in these 
cells.
WRN−/− and BLM−/− AP cells exhibit attenuated adipocyte differentiation capacity. To inves-
tigate later stages of adipocyte development, WRN+/+, WRN−/−, BLM+/+ and BLM−/− AP cells were next sub-
jected to a previously described adipocyte differentiation protocol33 (Fig. 6a). WRN−/− and BLM−/− AP cells 
differentiated less efficiently than wild-type counterparts as assessed by intensity of Oil Red O staining (Fig. 6b), 
and also adiponectin secretion in the case of the WRN knockout experiment, where differentiation of control 
cells was better (Fig. 6c). mRNA expression levels of adipocyte markers FABP4, CEBPA, GLUT4, ADIPOQ and 
PPARG2 assessed by qPCR were all found to be significantly downregulated in WRN−/− cells relative to WRN+/+ 
cells. BLM−/− cells were also found to express lower levels of FABP4, C/EBPα, GLUT4, ADIPOQ and PPARG2 
compared to BLM+/+ cells (Fig. 7a). WRN−/− and BLM−/− cells still showed increased mRNA expression of p16 
Figure 1. Generation of WRN−/− ESCs in the H9 background using CRISPR/Cas9. (a) Schematic of the WRN 
locus. Black boxes indicate exons. The sgRNA is designed to target exon 3 of the WRN gene. One of the clones 
with homozygous 1 bp insertion predicted to generate truncated WRN protein was selected for further study, 
together with one wild type clone. (b) WRN+/+ and WRN−/− ESCs were genotyped via Sanger sequencing. 
WRN−/− cells have an 1 bp insertion at position 161, creating a premature stop codon. (c) Western blot analysis 
of WRN+/+ and WRN−/− ESCs indicating absence of WRN protein in WRN−/− ESCs. The non-specific band 
is marked by an asterisk. Antibody used is specific to amino acids 1133–1432 at the C terminus of the WRN 
protein. Full-length blots can be found in Supplementary figure S4.
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(Fig. 7b). Expression of SASP component Activin A34–36, was also increased in both WRN−/− and BLM−/− cells 
relative to the wild-type cells (Fig. 7b), although whether this signal arose from postmitotic differentiated adipo-
cytes or residual senescent APs was not determined. Collectively our data show evidence of increased senescence 
from early stages of adipocyte development, with attenuated adipocyte differentiation in both WRN and BLM 
null human cells. This is consistent with the hypothesis that the lipodystrophy-like metabolic complications of WS 
and BS could arise from premature senescence in the adipocyte precursor compartment.
Figure 2. Targeting of BLM in H9 ESCs using CRISPR/Cas9. (a) Schematic of the BLM locus. Black boxes 
indicate exons. The sgRNA is designed to target exon 3 of the BLM gene. The clone with a homozygous 11 bp 
deletion predicted to generate a truncated version of the BLM protein was selected for further study, together 
with one wild type clone. (b) The genotypes of BLM+/+ and BLM−/− ESCs were assessed via Sanger sequencing. 
BLM−/− cells have an 11 bp deletion at position 379 (marked by the red box), resulting in a generation of a 
premature stop codon. (c) Representative images of metaphase chromosomes stained differentially with BrdU 
and acridine orange with BLM−/− exhibiting “harlequin chromosomes”, a phenotype indicative of Bloom 
Syndrome. Examples of SCE indicated by white arrows. (d) SCE events in 4 metaphase spreads were quantified 
and expressed as SCE events per chromosome. **p < 0.01. t test.
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Discussion
In recent years there has been growing interest in the role played by senescence in adipose tissue in obesity and/or 
ageing, with an increase in senescence of preadipocytes shown to decrease adipogenesis and yield lipodystrophy, 
lipotoxicity and inflammation19. Accumulation of DNA damage and/or telomere attrition trigger cellular senes-
cence, and this is a common feature of monogenic disorders of DNA damage repair. Only a subset of this large 
number of disorders features a “lipodystrophic” pattern of insulin resistance, however, including Werner and 
Bloom Syndrome. This led us to hypothesise a particular vulnerability to telomere attrition and senescence in the 
mesenchymal lineage leading ultimately to mature adipocytes.
Faithful in vivo models of WS and BS would be the ideal tool for dissection of this phenomenon, however 
although Wrn knockout mice have been generated, to date there are no BS mouse models, as loss of Blm caused 
embryonic lethality37,38. Furthermore only when the telomerase component Terc was also knocked in Wrn knock-
out mice, and when several generations were allowed to pass, did they display phenotypes resembling WS39. This 
implicated telomere attrition in WS, given the much longer telomeres found in mice than humans. This makes 
mice challenging from a practical, financial and ethical point of view as models of WS and emphasizes the need 
for human cells to model human disease.
Here we report successful generation of WRN−/− and BLM−/− ESCs and isogenic wild-type counterparts using 
CRISPR/Cas9. WRN-null hPSCs have previously been developed either by reprogramming WS dermal fibroblasts 
into induced pluripotent stem cells15,40 or by deleting exons 15 and 16 of the WRN gene in H9 and H1 cells16. 
Figure 3. Loss of WRN or BLM does not negatively impact proliferation rates, telomerase expression and 
telomere length in ESCs. (a) Cell proliferation rates of WRN+/+, WRN−/−, BLM+/+ and BLM−/− ESCs were 
assessed using the CyQuant cell proliferation assay. Data represent mean ± SD of three wells. n = 3. Statistical 
analysis was performed by fitting linear regression lines then testing for gradient equality. The p value was 
determined to be 0.7368 (WRN+/+ vs WRN−/−ESCs) and 0.9233 (BLM+/+ vs BLM−/− ESCs), indicating that 
the gradients of the lines were not significantly different from one another. (b) qPCR was performed using 
primers specific for telomeric ends and single copy reference gene 36B4. The relative telomere lengths were 
then determined by calculating the ratio between the telomeric DNA product and 36B4. Data are represented 
as means ± SD, n = 3. ns, not statistically significant. (c) mRNA from WRN+/+, WRN−/−, BLM+/+ and BLM−/− 
ESCs were extracted for qPCR analysis to determine the expression levels of telomerase complex genes TERT, 
TERC and DKC1. The housekeeping gene HPRT was used as a loading control. Data are represented as means ± 
SD, n = 3. **p < 0.01. ***p < 0.001, ns, not statistically significant. t test.
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Consistent with our findings, all reports agree on no overt differences between wild-type and WRN-null cells in 
maintenance of pluripotency15,16,40. To date, no BLM-null hPSCs have been reported although Blm-null mouse 
ESCs were first reported in 200441. This study is therefore the first to successfully model BS in hPSCs. Similar to 
the WRN−/− ESCs, the BLM−/− ESCs were capable of maintaining pluripotency and could be propagated over 
several passages without loss of pluripotency or proliferative capabilities. Although care was taken to utilise con-
trol cells that had gone through the same targeting procedure with the same guide RNA, albeit without editing of 
the target locus, and that had been subject to the same bottleneck of selection, a limitation of our study is that only 
single clones for each genotype were studied.
Upon differentiation of WRN−/− or BLM−/− ESCs into AP cells, premature senescence quickly emerged, as 
assessed by decreased proliferation, increased SA-β-gal staining, and transcriptional upregulation of senescence 
markers and SASP components. These findings in WRN−/− cells are consistent with previous reports15,16,40,42, 
which suggest that cells derived from the mesenchymal lineage are particularly susceptible to senescence in the 
absence of WRN15,43,44. Whether BS, like WS, also exhibits a segmental, or lineage restricted pattern of premature 
senescence remains to be determined. More generally, the determinants of this lineage specificity are unclear 
given that both WRN and BLM are ubiquitously expressed45,46.
WRN−/− and BLM−/− AP cells showed impaired differentiation into adipocytes compared to wild-type coun-
terparts, in keeping with senescence in the APs, which prior work suggests cells can autonomously induce senes-
cence and dysfunction of otherwise healthy cells through secretion of SASP components such as IL-647–49. Indeed 
this was upregulated in WRN−/− and BLM−/− AP cells compared to the wild-type. In addition to the WRN−/− and 
Figure 4. WRN+/+, WRN−/−, BLM+/+ and BLM−/− AP cells grow at a slower rate and exhibit defects in telomere 
maintenance. (a) Cell proliferation rates of WRN+/+, WRN−/−, BLM+/+ and BLM−/− AP cells assessed using 
the CyQuant cell proliferation assay kit. Data represent mean ± SD of three wells. n = 3. Statistical analysis 
was performed by fitting linear regression lines then testing for gradient equality. The p value was determined 
to be 0.002233 (WRN+/+ vs WRN−/− AP cells) and 0.01762 (BLM+/+ vs BLM−/−), indicating that the gradients 
of the lines are significantly different from one another. (b) The relative telomere lengths were determined by 
performing qPCR on genomic DNA extracted from WRN+/+, WRN−/−, BLM+/+ and BLM−/− AP cells and then 
calculating the ratio between the telomeric DNA product and 36B4. Data are represented as means ± SD, n = 3. 
**p < 0.01, t test. (c) mRNA from WRN+/+, WRN−/−, BLM+/+ and BLM−/− AP cells were extracted for cDNA 
synthesis and subsequently analysed via qPCR to determine the expression levels of telomerase complex genes 
TERT, TERC and DKC1. TERT expression levels were however, undetectable and was therefore not shown. The 
housekeeping gene HPRT was used to normalize for cDNA input. Data are represented as means ± , SD n = 3. 
*p < 0.05, **p < 0.01, ns, not statistically significant. t test.
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BLM−/− ESC lines generated using CRISPR/Cas9, we also attempted shRNA-mediated WRN or BLM knockdown 
in primary adipose-derived stem cells and the Simpson-Golabi-Behmel Syndrome (SGBS) human preadipocyte 
line. However, we were unable to sustain these cells in culture long enough for study due to rapidly increased 
senescence, consistent with observations in the WRN- and BLM-null ESC-derived APs. This adds to evidence that 
the lipodystrophy-like metabolic phenotype observed in WS and BS patients may be attributable to senescence 
in the adipose lineage.
Importantly, proof of the concept that clearance of senescent cells from ageing adipose tissue enhances meta-
bolic state has been established using both genetic and pharmacological approaches, and a growing raft of seno-
lytic agents is now available and being assessed in a variety of organ-specific disease models and in clinical trials. 
Activin A has been reported to impair adipogenesis through the activation of JAK/STAT35 and Smad2 signalling 
pathways36 in an autocrine/paracrine manner. Inhibition of Activin A has been shown to boost adipogenesis36, 
reducing lipotoxicity and improving insulin sensitivity34. As Activin A was upregulated in WRN−/− and BLM−/− 
AP cells, inhibitors targeting this pathway warrant assessment in BS and WS and their in vivo models where 
available. It will also be of great interest to extend findings from this study to other forms of monogenic severe 
insulin resistance caused by defects in genes involved in DNA damage repair and/or cell control (e.g. NSMCE250, 
POLD151, PCNT52, POC1A53) to establish if these are unified by a high propensity for senescence in the adipose 
lineage. This has the potential to define a rare disease target population where trials of senolytics may be of par-
ticular value.
Figure 5. Emergence of premature senescence phenotype in AP cells derived from WRN+/+, WRN−/−, BLM+/+ 
and BLM−/− ESCs. (a) Representative bright-field images of SA-β-gal-stained WRN+/+, WRN−/−, BLM+/+  
and BLM−/− AP cells. Images were captured at 40X magnification. (b) Quantification of SA-β-gal-positive 
cells. Positively stained cells from 5 random fields were quantified and plotted as means ± SD. n = 3. *p < 0.05, 
**p < 0.01. t test. (c) Senescence biomarkers, p16, p21, IL-6 and IL-8, were determined via qPCR in WRN+/+, 
WRN−/−, BLM+/+ and BLM−/− AP cells. *p < 0.05, **p < 0.01, ***p < 0.001. ****p < 0.0001. t test.
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Materials and Methods
Maintenance of H9 human embryonic stem cell (hESC) line. The human embryonic stem cell line H9 
(WiCell) was maintained on Matrigel (Corning)-coated plates at 37°C and 5% CO2, in mTeSR1 medium (Stem 
Cell Technologies). Fresh mTeSR1 medium was applied to the H9 cells every day. Cells were split at a 1:10 ratio 
approximately every 5 to 7 days when enlarging colonies began to merge.
CRISPR/Cas9 gene editing. The CRISPR plasmid construct pSpCas9(BB)-2A-Puro (pX459, Plasmid 
#48139) was obtained from Addgene. Single guide RNA (sgRNA) sequences were designed using a CRISPR 
design tool (http://crispr.mit.edu) and cloned into the pX459 plasmid. Sequences of sgRNAs are listed in Table S1. 
H9 cells were dissociated into single cells with Accutase (Stem Cell Technologies). Two million cells were elec-
troporated with 10 µg pX458-sgRNA using the program CA137 on the Lonza Amaxa 4D Nucleofector (Lonza). 
One day post electroporation, 1 µg/ml puromycin selection was applied to the cells for 48 hours. Cells were then 
fed fresh mTESR1 media every day until colonies large enough for manual picking and genotyping via Sanger 
sequencing. Sequences of genotyping primers are listed in Table S4. After targeting, ability of WRN+/+, WRN−/−, 
BLM+/+ and BLM−/− ESCs to differentiated into all 3 germ layers was verified as described by Vallier et al. 200954.
Sister chromatid exchange (Sce) assay. BLM+/+ and BLM−/− ESCs were grown to 80% confluence 
before they were treated with 10 μM BrdU (Thermofisher) for 48 hours, after which mitotic arrest was induced 
with 150 ng/ml Colcemid (Gibco) for 30 minutes. Cells were then incubated in 75 mM KCl for 15 minutes at 37°C 
before fixation in a solution of 3 parts methanol (Sigma-Aldrich) to 1 part glacial acetic acid (Sigma-Aldrich). 
The cell suspension was dropped onto pre-chilled slides, counterstained with 0.1 mg/ml acridine orange 
(Molecular Probes), and mounted in Sorenson Buffer, pH 6.8 (0.1 M Na2HPO4 (Sigma-Aldrich), 0.1 M NaH2PO4 
(Sigma-Aldrich)). Chromatids were visualized using the Zeiss LSM 510 Meta Laser Scanning Microscope (Carl 
Zeiss) under the FITC filter. SCE events in a metaphase spread was counted and normalized to the total number 
of chromosomes.
Figure 6. WRN−/− and BLM−/− AP cells differentiate poorly into adipocytes compared to their wild type 
counterparts. (a) Protocol for differentiating AP cells into mature adipocytes using a combination of PPARG2 
overexpression and an adipogenic cocktail. (b) Differentiated WRN+/+, WRN−/−, BLM+/+ and BLM−/− AP 
cells were stained with Oil Red O to allow visualization of lipid droplets as a measure of extent of adipocyte 
differentiation. (c) Media from differentiated WRN+/+, WRN−/−, BLM+/+ and BLM−/− AP cells were harvested 
and ELISA was performed to measure the levels of adiponectin secreted. n = 5. **p < 0.01, t test.
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Differentiation of hESCs into AP cells. Embryoid bodies (EBs) were derived from H9 cells as per Ahfeldt 
et al., 201233. Briefly, H9 colonies were detached from wells and broken into clumps of 5–10 cells in EB forma-
tion medium (15% Knockout serum replacement (Thermo Fisher Scientific), 1% GlutaMAX (Thermo Fisher 
Scientific) in DMEM (Sigma-Aldrich)) supplemented with 4 μM Y-27632 (Sigma-Aldrich). Cell clumps were 
seeded onto Ultralow attachment plates (Corning) and fed every other day for 5 days after which the EBs were 
collected and plated onto 0.1% gelatin-coated plates in EB plating medium (10% KnockOut serum replacement 
(Thermo Fisher Scientific), 1% Glutamax in DMEM (Passage number, P0). Upon reaching 90% confluency, 
the cellular outgrowths from the EBs were trypsinized and replated onto 0.1% gelatin-coated plates and fed AP 
medium (15% Knockout serum replacement, 1% GlutaMAX, 2.5 ng/ml bFGF (R&D Systems) in DMEM) every 
other day (P1). All experiments were performed on P1 AP cells.
Adipocyte differentiation of Ap cells. AP cells were differentiated into adipocytes as described by 
Ahfeldt et al., 201233. Briefly, AP cells were transduced with lenti-PPARγ2 viruses (described in Chen et al., 
201755) in the presence of 8 µg/ml polybrene. Adipocyte differentiation medium (15% knockout serum replace-
ment, 0.5% non-essential amino acids (Invitrogen), 1% Glutamax, 1 μM dexamethasone (Sigma-Aldrich), 10 μg/
ml insulin (Actrapid, Novo Nordisk), 0.5 μM rosiglitazone (Sigma-Aldrich) in DMEM) supplemented with 1 μg/
ml doxycycline (Sigma-Aldrich) was applied to confluent transduced AP cells to induce adipocyte differentiation. 
Adipocyte differentiation medium containing doxycycline was applied to the AP cells every other day for 21 days 
after which the cells were maintained in doxycycline-free differentiation medium for a further 7 days.
cell proliferation assay. Cells were dissociated to single cells and counted. Two thousand cells were seeded 
into each well of a 96-well plate in triplicate. Cells were harvested at 0, 2, 4, 6, 8, and 10 days and analyzed using 
the CyQuant Cell Proliferation assay (Invitrogen) per manufacturer’s guidelines. Fluorescence was measured at 
520 nm using the Tecan Infinite M1000 Pro Microplate Reader (Tecan).
Figure 7. Premature senescence of WRN−/− and BLM−/− AP cells impairs adipocyte differentiation, possibly 
through SASP-mediated mechanisms. (a) mRNA was extracted from differentiated WRN+/+, WRN−/−, BLM+/+ 
and BLM−/− AP cells and expression levels of adipocyte markers C/EBPα, FABP4, ADIPOQ, GLUT4 and 
PPARG2 were measured via qPCR and normalized to housekeeping gene, HPRT. n = 3. *p < 0.05. **p < 0.01. 
***p < 0.001. ****p < 0.0001. t test. (b) Expression of key senescence and SASP markers were determined via 
qPCR in differentiated WRN+/+, WRN−/−, BLM+/+ and BLM−/− AP cells and normalized to housekeeping gene 
HPRT. n = 3. *p < 0.05. **p < 0.01. ***p < 0.001. t test.
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telomere length measurement. Genomic DNA was extracted using the Gentra PureGene cell kit 
(Qiagen) according to manufacturer’s instructions. The protocol used for measuring telomere length was devel-
oped by Cawthon, 200232. Briefly, qPCR was performed using primers specific for telomeres (T) and single copy 
gene 36B4 (S). Primer sequences can be found in Table S1. T values were then normalized against S to obtain an 
index of relative telomere length.
SA-β-gal staining. AP cells fixed with 4% paraformaldehyde (Thermo Fisher Scientific) were incubated 
with X-gal solution (40 mM citric acid/Na phosphate buffer (Sigma-Aldrich)), 5 mM K4[Fe(CN)6]0.3H2O 
(Sigma-Aldrich), 5 mM K3[Fe(CN)6] (Sigma-Aldrich), 150 mM sodium chloride (CIMR), 2 mM magnesium 
chloride (Sigma-Aldrich) and 1 mg/ml X-gal (Sigma-Aldrich) in distilled water) for 16 hours at 37°C. Cells were 
washed twice with 1X DPBS. Images were captured at 40X magnification using the Olympus DP20 microscope 
camera attached to an Olympus CKX41 light microscope.
mRnA expression analysis. Total RNA was purified from cells using the RNeasy Mini Kit (Qiagen). 
DNase digestion removed contaminating DNA before first-strand cDNA synthesis with the ImProm-II Reverse 
Transcription System (Promega). qPCR was undertaken using the ABI PRISM 7900 Sequence Detection System 
(Applied Biosystems) with each well of a 384-well plate containing a 7 µl reaction volume made up of SYBR Green 
PCR Master Mix (Applied Biosystems), the appropriate primers (Table S1 and S2, Sigma-Aldrich) and 2 µl cDNA. 
The sample cycle threshold (Ct) values were then normalized against a standard curve generated with serial dilu-
tions of a neat cDNA standard made up of pooled cDNA samples. An internal housekeeping gene (human HPRT) 
was used to normalize the expression of the genes of interests.
protein expression analysis. Cells were washed in ice-cold DPBS and then lysed in 50–100 μl RIPA buffer 
(Sigma-Aldrich) supplemented with complete protease inhibitor cocktail (Roche) to extract total protein. Protein was 
resolved on NuPage 4–12% gradient Bis-Tris minigels (Invitrogen) with 1X MOPS buffer (Invitrogen) and then trans-
ferred onto a nitrocellulose membrane at 20 V for 7 to 10 minutes using the iBlot dry blotting system (Invitrogen). 5% 
powdered skimmed milk or 5% BSA, both diluted in Tris-buffered saline (TBST: 0.05 M Tris, 0.138 M NaCl, 0.0027 M 
KCl, pH 8.0) with 0.1% Tween-20 (Sigma-Aldrich) were used as blocking buffer. Membranes were incubated over-
night at 4 °C with the primary antibodies. Membranes were washed 3 times in TBST and then incubated with the 
appropriate HRP-linked secondary antibodies. The list of antibodies used in this study can be found in (Table S3). The 
membrane was then washed 3 times in TBST before the protein was interest was visualized using the EMD Millipore 
Immobilon Western Chemiluminescent HRP Substrate (ECL) (Millipore) and the ChemiDoc (Biorad).
immunostaining. Cells were fixed in 4% neutral-buffered formaldehyde (Sigma-Aldrich) and permeabilized 
and blocked in 10% donkey serum (Sigma-Aldrich) in 0.1% Triton X-100 in DPBS (PBST) for 20 minutes at RT. 
Cells were incubated with primary antibodies diluted in 1% donkey serum in PBST for 1 hour at RT before they 
were washed 3 times in DPBS. Appropriate Alexa-fluor-conjugated secondary antibodies diluted 1:1000 in 1% 
donkey serum in DPBS were applied to the cells for 30 minutes in the dark at RT. Antibodies used in this study are 
listed in Table S3. Cells were then washed 3 more times in DPBS. DAPI was diluted 1:10,000 in DPBS, added to 
the cells and incubated for 2 minutes at RT in the dark. Cells were washed a further 3 times with DPBS and then 
imaged using the EVOS FL imaging system (Life Technologies).
flow cytometry. AP cells were incubated in 0.125% trypsin-EDTA (Sigma-Aldrich) for 1 minute at 37 °C 
to detach them before resuspension in AP medium and transfer into a 15 ml falcon tube. 1 × 106 cells were 
transferred into each round-bottom polystyrene tube (BD Biosciences), washed once in fluorescence-activated 
cell sorting (FACS) buffer made up of 0.005 g/ml bovine serum albumin (BSA) (Sigma-Aldrich) in DPBS and 
then incubated with PE-labeled antibodies against CD73 (BD Biosciences) for 30 minutes in the dark at RT. 
Cells were pelleted by centrifuging at 1300 rpm for 3 minutes at RT and washed with FACS buffer. The cell pellet 
was resuspended in 100 μl 1X DPBS and analysed on a BD FACSCalibur flow cytometer with the percentage of 
CD73-expressing cells determined by acquiring 10,000 events per cell type. Data were analyzed using Flowing 
software developed by the Turku Center for Biotechnology (Finland).
oil Red o staining. Differentiated AP cells were fixed with 10% neutral-buffered formalin solution 
(Sigma-Aldrich) for 10 minutes at RT at day 28 then rinsed twice in 60% isopropanol. Freshly prepared Oil Red O 
working solution (6 parts 0.25% Oil Red O in isopropanol: 1 part 60% isopropanol: 3 parts water) was applied to cells 
for 30 minutes at RT. Excess Oil Red O stain was removed with 60% isopropanol washing before image acquisition.
Statistical analysis. The two-tailed Student’s T test was used to test for statistical significance where only 
a single parameter was compared between two groups. A p value of <0.05 was considered statistically signifi-
cant. All error bars indicate mean + /− standard deviation (SD). All statistical analyses were performed using 
GraphPad Prism 6.0 (GraphPad Software Inc., San Diego, CA).
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